OncoMatch/Clinical Trials/NCT05006482
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Is NCT05006482 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for lymphoma.
This phase III trial compares the effect of geriatric evaluation and management with survivorship health education (GEM-S) to usual care on patient-reported physical function in older survivors of cancer. Survivorship care for older adults of cancer usually consists of getting advice from their doctor. This advice may include how to do their daily activities, so they are less tired or how to manage multiple diseases, or long-term side effects from treatment. GEM-S may help improve the physical ability to perform activities of daily living, mental well-being, and memory in older survivors of cancer after chemotherapy. This study may help doctors learn if including GEM-S in their practices improves physical, mental and memory functions in their patients. The study may also help to understand how such care affects cancer patients and their caregivers' quality of life.
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Hodgkin Lymphoma
Tumor Agnostic
Prior therapy
Must have received: curative-intent treatment — curative
Have completed or will have completed curative-intent treatment (e.g., surgery, chemotherapy, chemotherapy with radiation) for any solid tumor or lymphoma malignancy in last 6 months
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Lewis and Faye Manderson Cancer Center · Tuscaloosa, Alabama
- Kaiser Permanente-Fremont · Fremont, California
- Kaiser Permanente-San Francisco · San Francisco, California
- Helen F Graham Cancer Center · Newark, Delaware
- Medical Oncology Hematology Consultants PA · Newark, Delaware
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify